Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Specjalistyczna Praktyka Lekarska prof. Grzegorz Opala

Verified siteinfo

Poland Fitelberga 34/1, 40-588 Katowice, Poland

  • Parkinson's disease · Multiple system atrophy · Relapsing multiple sclerosis
  • Adult patients

About Specializations

Specjalistyczna Praktyka Lekarska prof. Grzegorz Opala in Katowice, Poland specialises in clinical trials of conditions such as Parkinson's disease, Multiple system atrophy, Relapsing multiple sclerosis, Multiple sclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology and Multiple Sclerosis

The medical center is at the forefront of neurology research, with a particular focus on Multiple Sclerosis (MS). The institution is dedicated to advancing the understanding and treatment of this complex neurological disorder.

  • Long-term safety evaluations
  • Therapeutic efficacy studies
  • Patient-centered care approaches

Through its commitment to cutting-edge research, the center contributes significantly to the development of innovative therapies that aim to improve the quality of life for individuals living with MS.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Fitelberga 34/140-588 KatowicePoland
Open in maps ↗
Recruiting now
no trials
Conditions studied
4
Partner status
Verified site

More sites in KatowicePoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Multiple system atrophy+1

Not yet recruiting

Long-term safety and effectiveness follow-up study of AB-1005 gene therapy in patients with Parkinson's disease or multiple system atrophy

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carbidopa
  • Sponsor:Askbio Inc.

Parkinson's disease

Not recruiting

Study on the Long-Term Safety and Effectiveness of Minzasolmin and Iodine Ioflupane (123I) in Patients with Parkinson's Disease

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ioflupane (123I)
  • Sponsor:UCB Biopharma

Relapsing multiple sclerosis

Not recruiting

Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:LY3541860
  • Sponsor:Eli Lilly & Co.

Multiple sclerosis

Not recruiting

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.